AlzeCure Pharma Balance Sheet Health
Financial Health criteria checks 4/6
AlzeCure Pharma has a total shareholder equity of SEK14.0M and total debt of SEK0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are SEK22.7M and SEK8.7M respectively.
Key information
0%
Debt to equity ratio
kr0
Debt
| Interest coverage ratio | n/a |
| Cash | kr19.04m |
| Equity | kr13.97m |
| Total liabilities | kr8.72m |
| Total assets | kr22.69m |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: AC6's short term assets (SEK22.4M) exceed its short term liabilities (SEK8.7M).
Long Term Liabilities: AC6 has no long term liabilities.
Debt to Equity History and Analysis
Debt Level: AC6 is debt free.
Reducing Debt: AC6 has not had any debt for past 5 years.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: AC6 has less than a year of cash runway based on its current free cash flow.
Forecast Cash Runway: Insufficient data to determine if AC6 has enough cash runway if its free cash flow continues to grow or shrink based on historical rates.